ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $342,000 | +45.5% | 37,167 | +22.2% | 0.00% | – |
| Q4 2016 | $235,000 | -25.2% | 30,423 | +10.8% | 0.00% | -100.0% |
| Q3 2016 | $314,000 | -7.1% | 27,462 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $338,000 | +21.6% | 27,462 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $278,000 | -49.3% | 27,462 | +13.0% | 0.00% | 0.0% |
| Q4 2015 | $548,000 | +36.0% | 24,297 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $403,000 | -26.3% | 24,297 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $547,000 | +20.5% | 24,297 | +37.9% | 0.00% | 0.0% |
| Q1 2015 | $454,000 | +18.5% | 17,613 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $383,000 | +15.0% | 17,613 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $333,000 | -18.8% | 17,613 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $410,000 | +89.8% | 17,613 | +174.9% | 0.00% | – |
| Q1 2014 | $216,000 | +14.3% | 6,407 | 0.0% | 0.00% | – |
| Q4 2013 | $189,000 | +177.9% | 6,407 | +44.0% | 0.00% | – |
| Q3 2013 | $68,000 | – | 4,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|